Navigation Links
BioLineRx Presents Data on BL-1040 at Cardiovascular,Revascularization Therapies Conference Demonstrating Potential to,Reduce Deterioration of Infarcted Heart Tissue and Maintain,Functionality

istered via the coronary artery, as a liquid that is injected during catheterization into the damaged heart muscle. The liquid polymerizes within the tissue and forms a protective scaffold that enhances the mechanical strength of the heart muscle during recovery and repair thereby preventing pathological enlargement of the left ventricle after the heart attack. BL-1040 degrades naturally six weeks after injection.

Patients who have undergone an acute MI (AMI) with severe heart damage are the most likely to benefit from BL-1040. Approximately 40% of AMI patients develop left ventricle dilatation or heart failure, which carries a substantially greater mortality risk. This population includes approximately 380,000 patients in the U.S., with a total estimated U.S. market of over $1.5 billion.

BL-1040 was in-licensed from Ben-Gurion University through its business company BGN Technologies, and was developed by Professor Smadar Cohen and Professor Jonathan Leor from the Department of Biotech and Biomedical Engineering at Ben-Gurion University.

About BioLineRx

BioLineRx, a clinical stage drug development company traded on the Tel Aviv Stock Exchange (BLRX), is dedicated to building a robust pipeline of promising therapeutics for unmet medical needs. The Company's current product pipeline consists of 10 compounds, 3 of which are in or impending clinical trials. Its lead product, BL-1020, for the treatment of schizophrenia, successfully completed Phase 1 clinical trials; and BL-1040, for the treatment of damaged heart tissue post myocardial infarction, is expected to enter the clinic in the second quarter of 2007. Additional products under development include compounds for the treatment of cancer and CNS, cardiovascular, metabolic, infectious and autoimmune diseases.

BioLineRx advances projects from early stage discovery and lead generation to advanced clinical trials, regulatory approval and marketing. Partnering with researchers, universi
'"/>




Page: 1 2 3

Related medicine technology :

1. BioLineRx Presents Data From Successful Phase I Trial for BL-1020 in Schizophrenia at American Psychiatric Association Conference
2. BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming Clinical Conferences
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
5. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
6. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
7. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
8. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
9. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
10. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
11. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
Post Your Comments:
(Date:8/21/2014)... 2014 InfinityQS International, Inc., the global ... , today announces Infusion Chicago, its 9 th ... held Oct. 9-10, 2014, at the Chicago Marriott ... the necessity for implementing a quality system that ... to gain insight into production processes. Complimentary registrations ...
(Date:8/21/2014)... , Aug. 21, 2014 CVS Caremark Corporation (NYSE: ... applicable Reference Yields and consideration payable in connection with its ... August 7, 2014 for (1) any and all of its ... and (2) up to a maximum amount of its 6.125% ... 5.750% Senior Notes due 2017 (collectively, the "Maximum Tender Offer ...
(Date:8/21/2014)... , Aug. 21, 2014 /CNW/ - Bedrocan Cannabis ... three independent members to its Board of Directors, ... experience of the company, a leading licensed producer ... . Internationally, Bedrocan has 13 years, experience in ... in seven countries, including Canada. ...
Breaking Medicine Technology:InfinityQS to Host Manufacturing Intelligence Conference in Chicago 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 3CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 4CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 5CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 6Senior Life Sciences Executives Join Bedrocan as Independent Directors 2Senior Life Sciences Executives Join Bedrocan as Independent Directors 3
... REGENSBURG, Germany, June 2 The TGF-beta 2,inhibitor ... good safety,and tolerability in the systemic treatment of ... administered,intravenously, showed a clear proof of concept. Patients ... for seven days every other week,as second or ...
... Transplant Congress in Toronto, MIAMI, June 2 ... Departments of Surgery and Pathology at the University ... corroborated the value of,monitoring cell- mediated immunity (CMI) ... regular laboratory assay of cell function,(ImmuKnow(R)/Cylex). Their paper, ...
Cached Medicine Technology:Anti-TGF-Beta Antisense AP 12009 Shows Very Good Safety and Tolerability in Systemic Treatment of Pancreatic Carcinoma, Malignant Melanoma and Colorectal Carcinoma 2Anti-TGF-Beta Antisense AP 12009 Shows Very Good Safety and Tolerability in Systemic Treatment of Pancreatic Carcinoma, Malignant Melanoma and Colorectal Carcinoma 3Anti-TGF-Beta Antisense AP 12009 Shows Very Good Safety and Tolerability in Systemic Treatment of Pancreatic Carcinoma, Malignant Melanoma and Colorectal Carcinoma 4University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients 2University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients 3University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients 4
(Date:8/21/2014)... Pompano Beach, FL (PRWEB) August 21, 2014 ... potential, starts down the road to a serious substance abuse ... FL the best course of action is getting reliable help ... center. However, finding the right facility isn’t always easy for ... looking for assistance for a significant addiction issue. , ...
(Date:8/21/2014)... 2014 Sleep Apnea Doctors US is now ... provides doctors with a convenient way to find new patients ... that much closer to finding remedies for sleep apnea ... are experiencing this sleep disorder , thus the majority ... , Thanks to Sleep Apnea Doctors U.S., finding sleep doctors ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 ... high-quality patient safety and efficacy endpoint data ... 2014 Regional Conference Series: Maximizing Product Value ... 1-day educational events enable biopharmaceutical developers to ... in interactive discussions on developing, implementing, and ...
(Date:8/21/2014)... Which shirt do we put on in the morning? Do ... takeaway joint do we want to buy lunch? We make ... only have a minimal impact, it is extremely important for ... optimal as possible. People with ADHD often find this difficult, ... options which bring a prompt but smaller reward instead of ...
(Date:8/21/2014)... August 21, 2014 Bedros Keuilian’s Annual Fitness ... the industry, attended by many people already earning seven-figure incomes. ... is usually only open to the owners of Keuilian’s ... , This year’s Fit Body Boot Camp World Conference will ... a fitness boot camp or are struggling with ...
Breaking Medicine News(10 mins):Health News:Young Adults in Pompano Beach, FL Are Finding Success With Innovative New Helpline 2Health News:Sleep Apnea Doctors US is Now Offering Complimentary Listings to Sleep Apnea Doctors Across the United States 2Health News:ERT Opens Registration for PROFICIENCY™ Regional Conference Series 2Health News:ERT Opens Registration for PROFICIENCY™ Regional Conference Series 3Health News:ADHD children make poor decisions due to less differentiated learning processes 2Health News:Fitness Boot Camp Founder Offers Fifty Scholarships to Fit Body Boot Camp World Conference 2Health News:Fitness Boot Camp Founder Offers Fifty Scholarships to Fit Body Boot Camp World Conference 3
... than walking or running as kids age, researchers say , , ... many adolescents become less physically active and are more likely ... study finds. , Researchers asked secondary school students in Montreal ... and found that 94 percent of the students took part ...
... eating starts at home and that parents, dietary choices ... need rethinking, according to a study by researchers at ... examination of dietary intakes and patterns among U.S. families ... eating habits is weak. The results are published in ...
... Fla.--The combination of chemotherapies 5FU and oxaliplatin compared to ... cancer recurrence and promotes longer survival for patients under ... according to Mayo Clinic and Dana-Farber Cancer Institute scientists ... of Clinical Oncology,s (ASCO) annual meeting in Orlando, Fla. ...
... Symptoms Tracker Sheds Light on IBS Warning Signs; IBS ... To mark World Digestive Health Day, the American ... of this awareness day under the auspices of the ... two new interactive tools aimed at helping to provide ...
... Winner to be Recognized at Annual "Below the Belt" ... teamed up with the POISE(R) brand to recognize champions ... entries to the Passion Award sponsored by POISE(R).The Passion ... a pelvic floor champion. The survivor is a woman ...
... and groups across the country and around the globe are ... period. The purpose of Men,s Health Month is to ... detection and treatment of disease among men and boys. The ... the week ending on Father,s Day, a special awareness period ...
Cached Medicine News:Health News:Teens Likely to Trade Team Sports for Individual Exercise 2Health News:New study indicates that parents' influence on children's eating habits is small 2Health News:Chemotherapy combination outcomes differ for aged, younger colon cancer patients 2Health News:Chemotherapy combination outcomes differ for aged, younger colon cancer patients 3Health News:New Interactive Tools From ACG Aim to Bring Hope to Millions of IBS Patients Searching for Relief 2Health News:New Interactive Tools From ACG Aim to Bring Hope to Millions of IBS Patients Searching for Relief 3Health News:New Interactive Tools From ACG Aim to Bring Hope to Millions of IBS Patients Searching for Relief 4Health News:Women's Health Foundation, POISE(R) Brand Look for Passionate Women's Health Advocates 2Health News:Women's Health Foundation, POISE(R) Brand Look for Passionate Women's Health Advocates 3Health News:Join Men's Health Network in Celebration of Men's Health Month 2Health News:Join Men's Health Network in Celebration of Men's Health Month 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: